Relay Therapeutics (RLAY) Other Non Operating Income (2019 - 2026)
Relay Therapeutics (RLAY) posted quarterly Other Non Operating Income of $5.3 million for Q1 2026, down 32.1% year-over-year from $7.8 million in Q1 2025, and down 7.68% quarter-over-quarter from $5.7 million in Q4 2025.
Relay Therapeutics (RLAY) Other Non Operating Income (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Other Non Operating Income for 8 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 32.1% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $23.8 million (down 29.28% YoY), while the FY2025 annual figure was $26.3 million, down 24.46% from the prior year.
- Other Non Operating Income eased to $5.3 million in Q1 2026 per RLAY's latest filing, from $5.7 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $9.0 million in Q1 2024 and bottomed at $675000.0 in Q1 2022.
- Historically, Other Non Operating Income has averaged $6.2 million across 5 years, with a median of $6.9 million in 2023.
- Annual changes were most pronounced in 2022 — Other Non Operating Income jumped 1903.0% — and 2025, when it slumped 36.04%.
- Relay Therapeutics' Other Non Operating Income stood at $5.3 million in 2022, then surged by 62.7% to $8.7 million in 2023, then gained by 3.15% to $9.0 million in 2024, then slumped by 36.04% to $5.7 million in 2025, then slipped by 7.68% to $5.3 million in 2026.
- Business Quant data shows RLAY's Other Non Operating Income at $5.3 million in Q1 2026, $5.7 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.12 Mn |
| Mar 31, 2026 | 5.30 Mn |
| Dec 31, 2025 | 5.74 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 8.98 Mn |
| Sep 30, 2024 | 8.26 Mn |
| Jun 30, 2024 | 8.55 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 8.70 Mn |
| Sep 30, 2023 | 7.84 Mn |
| Jun 30, 2023 | 7.55 Mn |
| Mar 31, 2023 | 6.94 Mn |
| Dec 31, 2022 | 5.35 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 675,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 157,000.00 |